Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis.

Literature DB >> 20458074

Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis.

L C Wong-Kisiel¹, T Ji, D L Renaud, S Kotagal, M C Patterson, J Dalmau, K J Mack.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2010 PMID： 20458074 PMCID： PMC2875922 DOI： 10.1212/WNL.0b013e3181dd41a1

Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910

× No keyword cloud information.

7 in total

1. Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man.

Authors: María Elena Novillo-López; Jeffrey E Rossi; Josep Dalmau; Jaime Masjuan
Journal: Neurology Date: 2008-02-26 Impact factor: 9.910

2. Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab.

Authors: H Ishiura; S Matsuda; M Higashihara; M Hasegawa; A Hida; R Hanajima; T Yamamoto; J Shimizu; J Dalmau; S Tsuji
Journal: Neurology Date: 2008-12-02 Impact factor: 9.910

3. Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome.

Authors: Michael R Pranzatelli; Elizabeth D Tate; Anna L Travelstead; Jerry Barbosa; Robert A Bergamini; Lucy Civitello; David N Franz; Brian S Greffe; Robin D Hanson; Craig A Hurwitz; Karen A Kalinyak; Howard Kelfer; Yasmin Khakoo; John F Mantovani; Stacy H Nicholson; Joann M Sanders; Stephen Wegner
Journal: J Pediatr Hematol Oncol Date: 2006-09 Impact factor: 1.289

4. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors: Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal: Lancet Neurol Date: 2008-10-11 Impact factor: 44.182

5. The distinctive movement disorder of ovarian teratoma-associated encephalitis.

Authors: Timothy J Kleinig; Philip D Thompson; Walid Matar; Andrew Duggins; Thomas E Kimber; John G Morris; Christopher S Kneebone; Peter C Blumbergs
Journal: Mov Disord Date: 2008-07-15 Impact factor: 10.338

6. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents.

Authors: Nicole R Florance; Rebecca L Davis; Christopher Lam; Christina Szperka; Lei Zhou; Saba Ahmad; Cynthia J Campen; Heather Moss; Nadja Peter; Amy J Gleichman; Carol A Glaser; David R Lynch; Myrna R Rosenfeld; Josep Dalmau
Journal: Ann Neurol Date: 2009-07 Impact factor: 10.422

7. Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy.

Authors: Pitt Niehusmann; Josep Dalmau; Christian Rudlowski; Angela Vincent; Christian E Elger; Jeffrey E Rossi; Christian G Bien
Journal: Arch Neurol Date: 2009-04

7 in total

13 in total

Review 1. Autoimmune encephalitis in children.

Authors: Thaís Armangue; Mar Petit-Pedrol; Josep Dalmau
Journal: J Child Neurol Date: 2012-08-29 Impact factor: 1.987

Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis.

1. Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man.

2. Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab.

3. Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome.

4. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

5. The distinctive movement disorder of ovarian teratoma-associated encephalitis.

6. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents.

7. Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy.

Review 1. Autoimmune encephalitis in children.

Review 2. Movement disorders in paraneoplastic and autoimmune disease.

3. Current approaches to the treatment of paraneoplastic encephalitis.

4. Clinical Characteristics and Follow-up of South Indian Children with Autoimmune Encephalopathy.

Review 5. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

6. Rituximab for Treatment of Refractory Anti-NMDA Receptor Encephalitis in a Pediatric Patient.

7. Anti-NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders.

8. The rehabilitation of children with anti-N-methyl-D-aspartate-receptor encephalitis: a case series.

Review 9. Hyperkinetic Movement Disorder Emergencies.

Review 10. NMDA receptor antibody encephalitis.